Allogene Therapeutics, Inc. (ALLO)
USD 1.43
(3.26%)
USD 1.43
(3.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 642.83 Million USD | -21.32% |
| 2022 | 817.07 Million USD | -21.33% |
| 2021 | 1.03 Billion USD | -15.41% |
| 2020 | 1.22 Billion USD | 71.05% |
| 2019 | 717.8 Million USD | -7.24% |
| 2018 | 773.85 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 586.35 Million USD | -8.79% |
| 2024 Q2 | 646.88 Million USD | 10.32% |
| 2023 Q1 | 746.87 Million USD | -8.59% |
| 2023 FY | 642.83 Million USD | -21.32% |
| 2023 Q2 | 770.97 Million USD | 3.23% |
| 2023 Q3 | 712.32 Million USD | -7.61% |
| 2023 Q4 | 642.83 Million USD | -9.76% |
| 2022 Q1 | 964.63 Million USD | -7.12% |
| 2022 Q4 | 817.07 Million USD | -7.94% |
| 2022 FY | 817.07 Million USD | -21.33% |
| 2022 Q3 | 887.57 Million USD | -6.34% |
| 2022 Q2 | 947.64 Million USD | -1.76% |
| 2021 Q4 | 1.03 Billion USD | -3.76% |
| 2021 Q3 | 1.07 Billion USD | -4.21% |
| 2021 Q1 | 1.17 Billion USD | -3.97% |
| 2021 FY | 1.03 Billion USD | -15.41% |
| 2021 Q2 | 1.12 Billion USD | -4.44% |
| 2020 Q4 | 1.22 Billion USD | 0.44% |
| 2020 FY | 1.22 Billion USD | 71.05% |
| 2020 Q2 | 1.25 Billion USD | 82.79% |
| 2020 Q3 | 1.22 Billion USD | -2.86% |
| 2020 Q1 | 688.52 Million USD | -4.08% |
| 2019 Q3 | 695.54 Million USD | -5.24% |
| 2019 Q2 | 733.99 Million USD | -2.05% |
| 2019 Q1 | 749.36 Million USD | -3.16% |
| 2019 FY | 717.8 Million USD | -7.24% |
| 2019 Q4 | 717.8 Million USD | 3.2% |
| 2018 Q4 | 773.85 Million USD | 77.8% |
| 2018 FY | 773.85 Million USD | 0.0% |
| 2018 Q3 | 435.23 Million USD | 45.64% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | 298.84 Million USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | 56.801% |
| Alkermes plc | 2.13 Billion USD | 69.908% |
| Agenus Inc. | 313.91 Million USD | -104.782% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 83.215% |
| Aptorum Group Limited | 20.64 Million USD | -3014.507% |
| Ardelyx, Inc. | 297.57 Million USD | -116.022% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | 16.03% |
| Bicycle Therapeutics plc | 595.34 Million USD | -7.977% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -772.211% |
| ChromaDex Corporation | 54.96 Million USD | -1069.56% |
| Chimerix, Inc. | 212.77 Million USD | -202.122% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -2173.727% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -45.779% |
| CRISPR Therapeutics AG | 2.22 Billion USD | 71.168% |
| Precision BioSciences, Inc. | 159.78 Million USD | -302.324% |
| Dyadic International, Inc. | 8.21 Million USD | -7721.128% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -1925.321% |
| Fortress Biotech, Inc. | 167.52 Million USD | -283.724% |
| Lantern Pharma Inc. | 43.64 Million USD | -1372.788% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -298.444% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -4331.327% |
| Incyte Corporation | 6.78 Billion USD | 90.522% |
| IO Biotech, Inc. | 150.71 Million USD | -326.516% |
| Jaguar Health, Inc. | 50.76 Million USD | -1166.35% |
| Novavax, Inc. | 1.85 Billion USD | 65.352% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -68.987% |
| Opthea Limited | 188.79 Million USD | -240.502% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | 22.835% |
| ContextLogic Inc. | 423 Million USD | -51.971% |
| MiMedx Group, Inc. | 239.04 Million USD | -168.917% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -270.029% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -12334.704% |
| NextCure, Inc. | 129.41 Million USD | -396.714% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -1091.586% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -1650.216% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -1890.146% |
| Vaxcyte, Inc. | 1.4 Billion USD | 54.341% |
| PDS Biotechnology Corporation | 59.39 Million USD | -982.398% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -0.358% |
| Pharming Group N.V. | 462.85 Million USD | -38.885% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -1561.936% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -2.272% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -3296.999% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -3296.999% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -288.844% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -1319.474% |
| Acelyrin, Inc. | 742.69 Million USD | 13.445% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -9659.884% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -9939.622% |
| Summit Therapeutics Inc. | 202.94 Million USD | -216.748% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -764.33% |
| Senti Biosciences, Inc. | 119.48 Million USD | -438.011% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -181.524% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -282.245% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -7679.705% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -13366.029% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -37.009% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -419.872% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -133.802% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -35.952% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -6261.573% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -199.683% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -56679.746% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -55.334% |
| Immix Biopharma, Inc. | 19.92 Million USD | -3126.258% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -73.728% |
| MEI Pharma, Inc. | 41.37 Million USD | -1453.685% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -1883.697% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -88.627% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -448.379% |
| Fortress Biotech, Inc. | 167.52 Million USD | -283.724% |
| Precigen, Inc. | 151.04 Million USD | -325.599% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -1789.697% |
| AlloVir, Inc. | 190.79 Million USD | -236.924% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -70.762% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -26.988% |
| ImmuCell Corporation | 43.8 Million USD | -1367.393% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | 0.998% |
| Onconetix, Inc. | 88.82 Million USD | -623.741% |
| PureTech Health plc | 693.97 Million USD | 7.369% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -558.071% |
| Elevation Oncology, Inc. | 89.09 Million USD | -621.551% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -10264.995% |
| Seer, Inc. | 436.26 Million USD | -47.349% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -687.819% |
| Innoviva, Inc. | 1.24 Billion USD | 48.305% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -385.442% |
| ESSA Pharma Inc. | 149.12 Million USD | -331.081% |
| GlycoMimetics, Inc. | 45.31 Million USD | -1318.55% |
| GT Biopharma, Inc. | 14.1 Million USD | -4456.219% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -108.786% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -165.962% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -36.221% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -1167.998% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -575.164% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -101681.066% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -13.507% |
| Aptose Biosciences Inc. | 12.92 Million USD | -4874.539% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -2806.886% |
| Soligenix, Inc. | 9.79 Million USD | -6461.352% |
| Century Therapeutics, Inc. | 360.69 Million USD | -78.224% |
| Kura Oncology, Inc. | 448.93 Million USD | -43.192% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -136.208% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -3616.895% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -479.595% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -213.348% |
| Autolus Therapeutics plc | 375.38 Million USD | -71.249% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -155.463% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -80.987% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -1208.388% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | 2.768% |
| GRI Bio, Inc. | 2.95 Million USD | -21646.854% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -5961.512% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -276.997% |
| IGM Biosciences, Inc. | 423.41 Million USD | -51.823% |
| INmune Bio, Inc. | 57 Million USD | -1027.764% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -188.908% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -665.818% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -2361.387% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -9239.224% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -754.541% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -336.538% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -288.412% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -2.102% |
| Verastem, Inc. | 149.71 Million USD | -329.365% |
| Abeona Therapeutics Inc. | 64 Million USD | -904.401% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -25.516% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -316.192% |
| Histogen Inc. | 19.07 Million USD | -3270.403% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -2738.111% |
| Surrozen, Inc. | 46.08 Million USD | -1295.046% |
| Organovo Holdings, Inc. | 6.34 Million USD | -10025.012% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -14819.789% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -346.332% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -5346.848% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -754.064% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -7445.699% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -77.105% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -3452.685% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -49.705% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -4997.14% |
| Apollomics, Inc. | 55.38 Million USD | -1060.628% |
| Amarin Corporation plc | 831.68 Million USD | 22.707% |
| Mesoblast Limited | 669.15 Million USD | 3.933% |
| Turnstone Biologics Corp. | 112.81 Million USD | -469.815% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -11.65% |
| Synaptogenix, Inc. | 31.11 Million USD | -1966.092% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -5176.075% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -17.293% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -10847.01% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -8651.846% |
| Exelixis, Inc. | 2.94 Billion USD | 78.152% |
| Better Therapeutics, Inc. | 22.94 Million USD | -2701.887% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -76.342% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | 18.497% |
| NLS Pharmaceutics AG | 1.84 Million USD | -34711.152% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -7956.981% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -4274.529% |
| Gritstone bio, Inc. | 177.76 Million USD | -261.614% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -573.975% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -3498.854% |
| Avid Bioservices, Inc. | 336.55 Million USD | -91.004% |
| Insmed Incorporated | 1.32 Billion USD | 51.66% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -6576.506% |
| MediWound Ltd. | 66.45 Million USD | -867.269% |
| OmniAb, Inc. | 401.98 Million USD | -59.916% |
| Alector, Inc. | 621.82 Million USD | -3.379% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -79.263% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -11853.087% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -1033.911% |
| Zai Lab Limited | 1.03 Billion USD | 37.968% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -34.357% |
| Aura Biosciences, Inc. | 255.07 Million USD | -152.019% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | 14.292% |
| Immunic, Inc. | 54.29 Million USD | -1083.884% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -141.465% |
| Veracyte, Inc. | 1.13 Billion USD | 43.503% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -5337.274% |
| FibroGen, Inc. | 423.52 Million USD | -51.781% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -18198.804% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -13471.683% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -11739.757% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 94.358% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -7200.818% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -24.231% |
| TG Therapeutics, Inc. | 329.58 Million USD | -95.043% |
| Galecto, Inc. | 38.22 Million USD | -1581.631% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -2141.725% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 85.247% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -173.078% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -2487.702% |
| XBiotech Inc. | 227.24 Million USD | -182.885% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -573.975% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -350.797% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -124.834% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -402.731% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -68.282% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | 56.886% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -76.196% |
| Vaxxinity, Inc. | 44.35 Million USD | -1349.365% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -24.349% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -3354.38% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -110.732% |
| NexImmune, Inc. | 8.59 Million USD | -7380.112% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -5899.306% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -3653.269% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 98.057% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -2802.05% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -163778.246% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -270.877% |
| Ainos, Inc. | 31.84 Million USD | -1918.846% |
| Pluri Inc. | 39.52 Million USD | -1526.324% |
| Prothena Corporation plc | 696.38 Million USD | 7.689% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -127.46% |
| Celularity Inc. | 143.88 Million USD | -346.759% |
| Rallybio Corporation | 115.62 Million USD | -455.991% |
| Cue Biopharma, Inc. | 61.53 Million USD | -944.754% |
| MeiraGTx Holdings plc | 458.16 Million USD | -40.306% |
| Omeros Corporation | 378.26 Million USD | -69.942% |
| Humacyte, Inc. | 128.22 Million USD | -401.343% |
| Immunocore Holdings plc | 597 Million USD | -7.678% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -1956.486% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -838.037% |
| Blueprint Medicines Corporation | 1.04 Billion USD | 38.734% |
| CalciMedica, Inc. | 12.18 Million USD | -5175.642% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -153.435% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -276.13% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -106.677% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -13.716% |
| Pulmatrix, Inc. | 33.95 Million USD | -1793.036% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -2268.073% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -356.372% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | 50.588% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -393.772% |
| Cytokinetics, Incorporated | 824.31 Million USD | 22.016% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -2943.304% |
| Nutriband Inc. | 7.51 Million USD | -8451.601% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -714.192% |
| Vor Biopharma Inc. | 209.82 Million USD | -206.364% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 91.1% |
| Evogene Ltd. | 51.1 Million USD | -1157.973% |
| ProKidney Corp. | 420.55 Million USD | -52.856% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -1072.354% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -6652.292% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -17.654% |
| CorMedix Inc. | 82.05 Million USD | -683.375% |
| BioLineRx Ltd. | 63.92 Million USD | -905.611% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -59.684% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -2179.564% |
| Atai Life Sciences N.V. | 293.47 Million USD | -119.041% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -294.066% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -404.51% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -14.378% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -564.644% |
| MediciNova, Inc. | 66.26 Million USD | -870.027% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -630.929% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -14305.747% |
| GeoVax Labs, Inc. | 9.28 Million USD | -6824.721% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -9.282% |
| Biomea Fusion, Inc. | 199.92 Million USD | -221.536% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | 66.223% |
| Mereo BioPharma Group plc | 66.49 Million USD | -866.687% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -32.517% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -4.888% |
| Absci Corporation | 234.48 Million USD | -174.154% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -8687.929% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -89.13% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -289.405% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -22.138% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -131.492% |
| Allakos Inc. | 243.61 Million USD | -163.88% |
| Imunon, Inc. | 21.91 Million USD | -2832.909% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -149.457% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -3.43% |
| BioAtla, Inc. | 119.65 Million USD | -437.229% |
| NLS Pharmaceutics AG | 1.84 Million USD | -34711.152% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -19863.882% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -570.076% |
| XOMA Corporation | 234.3 Million USD | -174.364% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -190.567% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -410.821% |
| aTyr Pharma, Inc. | 122.06 Million USD | -426.626% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -317.69% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -10.782% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -31.078% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -481.916% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -4141.032% |
| Akari Therapeutics, Plc | 4.35 Million USD | -14660.896% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -3673.108% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | 62.912% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -20744.355% |
| UroGen Pharma Ltd. | 178.31 Million USD | -260.514% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -36.56% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -115577.461% |
| Orgenesis Inc. | 14.55 Million USD | -4317.516% |
| Entera Bio Ltd. | 11.76 Million USD | -5363.978% |
| GH Research PLC | 226.3 Million USD | -184.064% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -1075.334% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -498.344% |
| Xencor, Inc. | 952.69 Million USD | 32.524% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -8158.683% |
| Replimune Group, Inc. | 487.72 Million USD | -31.804% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -7864.687% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | 0.864% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -20744.355% |
| Portage Biotech Inc. | 7.77 Million USD | -8163.749% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -14305.747% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -132.117% |
| OncoCyte Corporation | 74.89 Million USD | -758.352% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -31516.261% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -11008.98% |
| Purple Biotech Ltd. | 44.3 Million USD | -1351.034% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -1783.716% |
| scPharmaceuticals Inc. | 94.47 Million USD | -580.402% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -3462.419% |
| HilleVax, Inc. | 344.43 Million USD | -86.636% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -20140.46% |
| Tharimmune, Inc. | 10.94 Million USD | -5772.592% |
| Genprex, Inc. | 10.67 Million USD | -5924.38% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -29.553% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -567.869% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -26397.815% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -15332.628% |
| OKYO Pharma Limited | 1.54 Million USD | -41608.429% |
| Savara Inc. | 177.56 Million USD | -262.031% |
| Curis, Inc. | 77.28 Million USD | -731.807% |
| Daré Bioscience, Inc. | 21.28 Million USD | -2920.536% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -905.237% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -7850.0% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -3218.554% |
| BeiGene, Ltd. | 5.8 Billion USD | 88.927% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -5182.579% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | 69.221% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -79.588% |
| Erasca, Inc. | 395.29 Million USD | -62.621% |
| bluebird bio, Inc. | 619.16 Million USD | -3.824% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -14768.89% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 90.604% |
| DBV Technologies S.A. | 182.98 Million USD | -251.304% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -14768.89% |
| Moderna, Inc. | 18.42 Billion USD | 96.511% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -3428.775% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -5448.395% |
| Molecular Templates, Inc. | 35.38 Million USD | -1716.796% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -364.931% |
| Travere Therapeutics, Inc. | 788.91 Million USD | 18.516% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -111.63% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -518.434% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -38.058% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -105.093% |
| MacroGenics, Inc. | 306.82 Million USD | -109.516% |
| RenovoRx, Inc. | 1.46 Million USD | -43749.727% |
| Adicet Bio, Inc. | 207.29 Million USD | -210.107% |
| Prime Medicine, Inc. | 193.85 Million USD | -231.614% |
| Aditxt, Inc. | 44.57 Million USD | -1342.039% |
| Adagene Inc. | 115.72 Million USD | -455.468% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -14332.19% |
| Quantum-Si incorporated | 298.25 Million USD | -115.536% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | 56.783% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -8238.653% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -82.998% |
| SciSparc Ltd. | 11.18 Million USD | -5648.855% |
| Vericel Corporation | 353.65 Million USD | -81.768% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -5163.716% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -1029.754% |
| Generation Bio Co. | 374.75 Million USD | -71.534% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -152.424% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -305.404% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -88.314% |
| Invivyd, Inc. | 229.18 Million USD | -180.493% |
| Relay Therapeutics, Inc. | 843.98 Million USD | 23.833% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -5182.448% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -252.452% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -3047.459% |
| 2seventy bio, Inc. | 565.42 Million USD | -13.691% |
| ADMA Biologics, Inc. | 329.18 Million USD | -95.283% |
| Clene Inc. | 52.34 Million USD | -1128.171% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -994.483% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -394.894% |
| GeoVax Labs, Inc. | 9.28 Million USD | -6824.721% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | 1.662% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -520.432% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -393.026% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -558.968% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -805.442% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -165.029% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | 67.204% |
| Evaxion Biotech A/S | 12.88 Million USD | -4887.633% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -155.033% |
| Verve Therapeutics, Inc. | 752.68 Million USD | 14.594% |
| Trevena, Inc. | 40.6 Million USD | -1483.147% |
| Surrozen, Inc. | 46.08 Million USD | -1295.046% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -184.621% |
| Cingulate Inc. | 3.49 Million USD | -18311.823% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -3765.759% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -878.592% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -5401.562% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -139.403% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | 14.169% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -410.626% |
| Clearmind Medicine Inc. | 4.32 Million USD | -14765.383% |
| Kronos Bio, Inc. | 213.27 Million USD | -201.407% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -302.316% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -7409.243% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -74.452% |
| Statera Biopharma, Inc. | 21.16 Million USD | -2936.592% |
| ImmunityBio, Inc. | 504.45 Million USD | -27.433% |
| Korro Bio, Inc. | 221.66 Million USD | -190.006% |
| Kineta, Inc. | 10.28 Million USD | -6152.67% |
| BioVie Inc. | 25.2 Million USD | -2450.096% |
| Codexis, Inc. | 136.56 Million USD | -370.732% |
| Celularity Inc. | 143.88 Million USD | -346.759% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -1.178% |
| Celcuity Inc. | 191.21 Million USD | -236.178% |
| Virax Biolabs Group Limited | 5.48 Million USD | -11622.112% |
| Cibus, Inc. | 544.41 Million USD | -18.079% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -410.618% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -3029.074% |
| IN8bio, Inc. | 33.7 Million USD | -1807.019% |
| Kodiak Sciences Inc. | 479.37 Million USD | -34.1% |
| Annexon, Inc. | 297.67 Million USD | -115.953% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -271.561% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -367.623% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -2962.149% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 78.501% |
| Eyenovia, Inc. | 28.77 Million USD | -2133.673% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -178.854% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -8798.63% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -955.111% |
| Arcellx, Inc. | 825.13 Million USD | 22.093% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -687.433% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -39.059% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -1990.527% |
| Moolec Science SA | 24.05 Million USD | -2572.776% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -107.283% |
| Geron Corporation | 394.07 Million USD | -63.125% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -532.029% |
| Royalty Pharma plc | 16.38 Billion USD | 96.076% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -8.046% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -9090.193% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -5244.808% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -184.366% |
| Humacyte, Inc. | 128.22 Million USD | -401.343% |
| Structure Therapeutics Inc. | 482.01 Million USD | -33.364% |
| 89bio, Inc. | 596.26 Million USD | -7.81% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -154.94% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -34647.946% |
| Genelux Corporation | 27.89 Million USD | -2204.653% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -619.033% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -180.19% |
| Notable Labs, Ltd. | 19.54 Million USD | -3189.683% |
| Liquidia Corporation | 120.43 Million USD | -433.78% |
| Mustang Bio, Inc. | 17.74 Million USD | -3523.25% |
| Immunovant, Inc. | 666.71 Million USD | 3.581% |
| Quantum-Si incorporated | 298.25 Million USD | -115.536% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -345.175% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -1086.922% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -266.193% |
| Acasti Pharma Inc. | 73.3 Million USD | -776.995% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -14021.206% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -2361.387% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | 33.371% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -12286.265% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -2721.812% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -1145.736% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -255.766% |
| PepGen Inc. | 143.05 Million USD | -349.373% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -1582.071% |
| United Therapeutics Corporation | 7.16 Billion USD | 91.031% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -3250.727% |
| Solid Biosciences Inc. | 164.93 Million USD | -289.742% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -10847.01% |
| Immuneering Corporation | 102.58 Million USD | -526.641% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -14819.789% |
| Silo Pharma, Inc. | 7.74 Million USD | -8198.803% |
| Belite Bio, Inc | 94.64 Million USD | -579.23% |
| XOMA Corporation | 234.3 Million USD | -174.364% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -175.673% |
| Bionomics Limited | 27.64 Million USD | -2224.984% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -60.147% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -498.612% |
| uniQure N.V. | 831.68 Million USD | 22.707% |
| Cassava Sciences, Inc. | 151.66 Million USD | -323.859% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -14332.19% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -134.711% |
| Forte Biosciences, Inc. | 38.98 Million USD | -1549.146% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -15682.446% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -1645.369% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -8798.63% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -18198.804% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -5338.093% |
| Altimmune, Inc. | 210.64 Million USD | -205.183% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | 17.36% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -498.612% |
| Compugen Ltd. | 121.33 Million USD | -429.808% |
| Peak Bio, Inc. | 2.59 Million USD | -24658.638% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -273.033% |
| Benitec Biopharma Inc. | 52.21 Million USD | -1131.253% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -88.042% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -1748.667% |
| Zura Bio Limited | 100.84 Million USD | -537.463% |
| PolyPid Ltd. | 15.37 Million USD | -4081.87% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -438.904% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -1748.667% |
| Instil Bio, Inc. | 325.63 Million USD | -97.413% |
| argenx SE | 4.54 Billion USD | 85.848% |
| Immunome, Inc. | 148.54 Million USD | -332.77% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -309.777% |
| Verona Pharma plc | 308.12 Million USD | -108.629% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -639.241% |
| Shattuck Labs, Inc. | 159.56 Million USD | -302.871% |
| CervoMed Inc. | 9.97 Million USD | -6346.083% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -241.107% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -5544.863% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -258.316% |
| Moolec Science SA | 24.05 Million USD | -2572.776% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -10408.199% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -271.701% |
| AnaptysBio, Inc. | 452.38 Million USD | -42.098% |
| Design Therapeutics, Inc. | 289.64 Million USD | -121.941% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -782.715% |
| NeurAxis, Inc. | 509.49 Thousand USD | -126070.662% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -11764.839% |
| Lumos Pharma, Inc. | 40.63 Million USD | -1481.862% |
| Achilles Therapeutics plc | 161.45 Million USD | -298.15% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -639.241% |
| 180 Life Sciences Corp. | 5.25 Million USD | -12122.453% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -812.76% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -7409.243% |
| Nutriband Inc. | 7.51 Million USD | -8451.601% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -152.404% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -222.546% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -743.485% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -1009.947% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -22.087% |
| Palisade Bio, Inc. | 14.05 Million USD | -4474.701% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -205.683% |
| Beam Therapeutics Inc. | 1.45 Billion USD | 55.961% |
| Neurogene Inc. | 222.57 Million USD | -188.821% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | 0.585% |
| AEON Biopharma, Inc. | 6.84 Million USD | -9291.337% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -41.895% |
| Sesen Bio, Inc. | 189.17 Million USD | -239.813% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -136.453% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -4588.179% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | 17.622% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -140.768% |
| Athira Pharma, Inc. | 160.24 Million USD | -301.159% |
| Vaccinex, Inc. | 3.63 Million USD | -17604.131% |
| HCW Biologics Inc. | 28.51 Million USD | -2154.488% |
| XOMA Corporation | 234.3 Million USD | -174.364% |
| Nektar Therapeutics | 398.03 Million USD | -61.503% |
| Arvinas, Inc. | 1.3 Billion USD | 50.725% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -3673.108% |
| Merus N.V. | 458.49 Million USD | -40.206% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -214.552% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -256.727% |
| Rezolute, Inc. | 132.73 Million USD | -384.294% |
| Clene Inc. | 52.34 Million USD | -1128.171% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -4207.439% |
| BeyondSpring Inc. | 24.8 Million USD | -2491.249% |
| Synlogic, Inc. | 75.55 Million USD | -750.876% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -5319.297% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -6764.983% |
| Peak Bio, Inc. | 2.59 Million USD | -24658.638% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -267.686% |
| Krystal Biotech, Inc. | 818.35 Million USD | 21.448% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -167.361% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | 11.429% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -17870.526% |
| MannKind Corporation | 475.19 Million USD | -35.278% |
| Ikena Oncology, Inc. | 192.09 Million USD | -234.651% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -4706.617% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -451.607% |
| Gossamer Bio, Inc. | 311.91 Million USD | -106.093% |
| CohBar, Inc. | 16.36 Million USD | -3827.961% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -1728.163% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -8687.929% |
| Legend Biotech Corporation | 1.84 Billion USD | 65.226% |
| Mural Oncology plc | 301.74 Million USD | -113.04% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -1959.385% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -11216.746% |
| Disc Medicine, Inc. | 367.99 Million USD | -74.686% |
| Champions Oncology, Inc. | 26.13 Million USD | -2359.961% |
| REGENXBIO Inc. | 573.97 Million USD | -11.998% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -23637.697% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -316.383% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -5223.446% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -89.05% |
| Vaxart, Inc. | 91.83 Million USD | -600.029% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -973.114% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -333.392% |
| Cellectis S.A. | 334.27 Million USD | -92.311% |
| Longeveron Inc. | 12.17 Million USD | -5178.675% |
| Repare Therapeutics Inc. | 253.9 Million USD | -153.184% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 80.309% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -220.063% |
| Revolution Medicines, Inc. | 2.08 Billion USD | 69.221% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -39459.2% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -131.477% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -294.142% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -363.326% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -2418.756% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 97.172% |
| Denali Therapeutics Inc. | 1.15 Billion USD | 44.291% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -5163.716% |
| Veru Inc. | 50.59 Million USD | -1170.531% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -1311.185% |
| Cingulate Inc. | 3.49 Million USD | -18311.823% |
| Passage Bio, Inc. | 150.54 Million USD | -327.007% |
| Context Therapeutics Inc. | 16.06 Million USD | -3902.04% |
| Exicure, Inc. | 11.58 Million USD | -5451.269% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -70.945% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -297.692% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -3579.241% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -93.192% |
| Nuvalent, Inc. | 732.38 Million USD | 12.227% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -4201.617% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -617.821% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -4429.892% |
| OmniAb, Inc. | 401.98 Million USD | -59.916% |
| Anew Medical, Inc. | 19.45 Million USD | -3204.063% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -2305.237% |
| Lipocine Inc. | 23 Million USD | -2694.813% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -359.803% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -110.377% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -665.818% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -428.91% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -8001.285% |
| Sage Therapeutics, Inc. | 882.27 Million USD | 27.139% |
| Ocugen, Inc. | 64.54 Million USD | -895.921% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -416.165% |
| Q32 Bio Inc. | 306.11 Million USD | -109.996% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -15176.545% |
| Alumis Inc. Common Stock | 89.61 Million USD | -617.356% |
| Equillium, Inc. | 50.53 Million USD | -1172.189% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -754.893% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -1457.505% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -37694.977% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -2359.114% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -897.559% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -17147.585% |
| Dominari Holdings Inc. | 57.55 Million USD | -1016.851% |
| Edesa Biotech, Inc. | 8.89 Million USD | -7130.657% |
| vTv Therapeutics Inc. | 11.01 Million USD | -5734.425% |
| Bio-Techne Corporation | 2.81 Billion USD | 77.149% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | 31.403% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | 20.779% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -131.515% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -1441.502% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | 3.708% |
| Nkarta, Inc. | 378.88 Million USD | -69.665% |
| BioCardia, Inc. | 2.98 Million USD | -21421.158% |
| Iterum Therapeutics plc | 26.25 Million USD | -2348.064% |